NCT02586857 2026-03-25A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)Acerta Pharma BVPhase 1/2 Active not recruiting24 enrolled 10 charts